SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (995)10/24/2005 2:01:30 PM
From: jbn3  Respond to of 3557
 
I notice that REGN is up ~20% today ($1.70). However, I'm unable to find any news. Does anyone know what is causing this move?

jbn3



To: Miljenko Zuanic who wrote (995)10/24/2005 2:06:28 PM
From: jbn3  Read Replies (1) | Respond to of 3557
 
Finally found it on Yahoo.

biz.yahoo.com

Morgan Stanley has raised its rating to "overweight" and raised its target price from $10 to $16. The elevation was due to their expectation that the VEGF Trap will be competitive with Genentech's Avastin.

jbn3